Olin Q3 2026 Earnings: Sales Edge Higher as Profit Falls

Olin Corporation (NYSE: OLN) reported Q3 2026 sales of $1.7477 billion, up about 2.0% from $1.7132 billion a year earlier, while diluted EPS fell to $0.13 from $0.37. Net income attributable to Olin declined to $14.4 million from $42.8 million, and adjusted EBITDA fell to $191.4 million as weakness in Chlor Alkali Products and Vinyls outweighed improvements in Epoxy and Winchester.

Core Earnings Data

Higher Epoxy and Winchester sales lifted Olin’s total revenue, but the business mix was less favorable for earnings. Chlor Alkali Products and Vinyls recorded lower volumes, a smaller hydrogen production tax-credit benefit, and a $32.1 million impact from operating issues at the Freeport, Texas, vinyl chloride monomer plant.

GAAP results also included $13.7 million of acquisition-related costs for the proposed Huntsman merger and $1.7 million of restructuring charges. Adjusted EBITDA excluded both items but still declined by about 13.9%, indicating that the earnings pressure was not solely transaction-related.

The year-over-year decline in net income was also affected by the tax line, which moved from a $2.2 million benefit in Q3 2025 to a $2.7 million provision in Q3 2026.

Business and Segment Performance

Olin’s segments moved in different directions. Epoxy and Winchester generated a combined $47.3 million improvement in segment earnings, but that did not fully offset the $56.3 million decline in Chlor Alkali Products and Vinyls.

Chlor Alkali sales declined because of lower trading volumes following the conclusion of Blue Water Alliance operations at the end of 2025 and lower VCM volumes. Higher pricing provided a partial offset. Segment earnings included a $5.0 million clean hydrogen production tax-credit benefit, down from $32.0 million a year earlier, while the Freeport VCM operating issues raised costs and reduced profit from lost sales by $32.1 million.

Epoxy returned to a small segment profit from a $32.2 million loss. Higher volumes and lower operating costs drove the improvement, while higher pricing offset increased benzene and propylene costs, leaving product margins comparable with the prior year.

Winchester benefited from higher commercial ammunition volume and pricing. These gains more than offset higher raw material expenses, particularly commodity metal costs.

Profitability, Cash Flow, and Balance Sheet

Olin generated $69.7 million of operating cash flow during the first nine months of 2026, down from $153.0 million in the comparable 2025 period. Receivables used $133.4 million of cash and inventories used another $81.0 million, contributing to the weaker cash conversion. Capital expenditures were $106.6 million, meaning operating cash flow did not cover capital spending during the period.

Cash increased to $214.8 million at September 30 from $167.6 million at the end of 2025, supported by net financing cash flow of $86.6 million. However, total debt rose to $3.0131 billion from $2.8273 billion, and net debt increased to $2.7983 billion from $2.6597 billion.

The net debt-to-adjusted EBITDA ratio rose to 5.2 times from 4.1 times at year-end. This reflected both higher net debt and a decline in trailing-12-month adjusted EBITDA to $536.6 million from $651.8 million. Olin reported approximately $1.3 billion of available liquidity, including the undrawn portion of its revolving credit facility.

Earnings Guidance

Olin expects a substantial sequential decline in adjusted EBITDA during Q4 2026. Management attributed the outlook to normal seasonality, elevated year-end customer destocking in Chemicals, higher feedstock costs, continued pressure from subsidized Asian exports, and significant planned maintenance turnarounds.

The $90 million midpoint is approximately 53% below Q3 adjusted EBITDA, underscoring the expected near-term effect of destocking, maintenance, and input-cost pressure.

Management Commentary

CEO Ken Lane said Olin restored normal operations at its VCM assets during the quarter. Management maintained its value-focused participation strategy in Chlor Alkali despite weak global demand, while structural cost reductions and volume growth supported the Epoxy improvement. Winchester implemented pricing actions to address higher metals and other raw material costs.

Olin and Huntsman shareholders have approved their proposed all-stock merger of equals, and the waiting period under the Hart-Scott-Rodino Act has expired. Olin expects the transaction to close in Q1 2027, subject to remaining regulatory approvals and customary closing conditions. Q3 results included $13.7 million of costs associated with the pending merger, while permitted pre-close integration planning continued.

Recent Insider Transactions

The supplied insider-transaction summary showed no purchase or sale transactions in its latest six-month aggregation and listed total insider holdings of approximately 433,130 shares. Among the recent detailed records, three entries disclosed a transaction type, per-share price, and reported value; the source did not provide share quantities for these entries.

These transactions are presented as reported and do not, by themselves, establish insiders’ views on Olin’s outlook.

Risks Investors Need to Watch

• A weaker Q4 earnings outlook: Customer destocking, higher feedstock costs, Asian export pressure, and planned maintenance underpin adjusted EBITDA guidance well below the Q3 result.
• Chlor Alkali operating and demand pressure: The Freeport VCM issues reduced Q3 profit by $32.1 million, while challenging global demand and lower trading volumes weighed on segment sales.
• Leverage and cash conversion: Nine-month operating cash flow declined and did not cover capital expenditures, while the net debt-to-adjusted EBITDA ratio increased to 5.2 times.
• Raw material costs: Higher benzene and propylene costs affected Epoxy, while higher commodity metal costs partially offset Winchester’s pricing and volume gains.
• Merger execution: The Huntsman transaction remains subject to regulatory approvals and closing conditions, and Olin is already incurring acquisition and integration-planning expenses.

Summary

Olin’s Q3 2026 sales increased modestly, but lower Chlor Alkali earnings, VCM operating issues, a smaller tax-credit benefit, and merger-related costs contributed to a much steeper decline in profit. Epoxy and Winchester improved, but not enough to offset the core chemicals pressure. The main areas to monitor are the expected Q4 EBITDA decline, cash generation and leverage, sustained VCM reliability, and progress toward closing the Huntsman merger.